epocrates logo
epocrates logo
epocrates logo
  • Home
  • Search
  • Tools
  • Saved
  • 0
    Notifications
  • CME
  • Help & Feedback
  • About Us
  • Business Solutions
ProfileSign in

The clinical information you need, at your fingertips.

Medical News for You

Internally Generated Content

epocrates

2mo

Test created by integration tests

Hadlima (adalimumab) - indicated for 1) moderate to severe rheumatoid arthritis in adult patients, 2) psoriatic arthritis in adult patients, 3) ankylosing spondylitis in adult patients, 4) moderate to severe Crohn disease in adult and pediatric patients 6 years and older, 5) various other indications.

Internally Generated Content

epocrates

2mo

Test created by integration tests

Hadlima (adalimumab) - indicated for 1) moderate to severe rheumatoid arthritis in adult patients, 2) psoriatic arthritis in adult patients, 3) ankylosing spondylitis in adult patients, 4) moderate to severe Crohn disease in adult and pediatric patients 6 years and older, 5) various other indications.

Internally Generated Content

Pediatrics

2mo

Testing 4 March - Early allergen introduction linked to decline in pediatric food allergy rates (testing chronologically 2:53pm ist)

testing anesthelogy

Internally Generated Content

Pediatrics

2mo

Testing 4 March - Early allergen introduction linked to decline in pediatric food allergy rates (testing chronologically 2:51pm ist)

fgsfgdsfd

Internally Generated Content

Pediatrics

2mo

Testing 4 March - Early allergen introduction linked to decline in pediatric food allergy rates (test 10:17 ist) (3)

fgsfgdsfd

Journal Article Synopsis

Sleep Med Rev

2mo

Melatonin timing, dose key to improving sleep in neuropsychiatric pediatric patients (testing for chronological ) (1)

Effective dose and timing for melatonin in children with neuropsychiatric conditions remain undefined ...

Internally Generated Content

epocrates

2mo

Test created by integration tests

Hadlima (adalimumab) - indicated for 1) moderate to severe rheumatoid arthritis in adult patients, 2) psoriatic arthritis in adult patients, 3) ankylosing spondylitis in adult patients, 4) moderate to severe Crohn disease in adult and pediatric patients 6 years and older, 5) various other indications.

Journal Article Synopsis

Sleep Med Rev

2mo

Melatonin timing, dose key to improving sleep in neuropsychiatric pediatric patients (testing)

Effective dose and timing for melatonin in children with neuropsychiatric conditions remain undefined ...

Internally Generated Content

epocrates

2mo

Test created by integration tests

Hadlima (adalimumab) - indicated for 1) moderate to severe rheumatoid arthritis in adult patients, 2) psoriatic arthritis in adult patients, 3) ankylosing spondylitis in adult patients, 4) moderate to severe Crohn disease in adult and pediatric patients 6 years and older, 5) various other indications.

Internally Generated Content

Pediatrics

3mo

Testing 18 Feb - Early allergen introduction linked to decline in pediatric food allergy rates (test 10:17 ist) (2)

fgsfgdsfd

Trending icon

TRENDING THIS WEEK

EPOCRATES CME

View Catalog

view all CME activities
learn more about epocrates plus

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

About Us

Features

Business Solutions

Help & Feedback

Terms of Use

Privacy Policy

visit epocrates on instagram
visit epocrates on facebook
visit epocrates on youtube
visit epocrates on twitter
visit epocrates on linkedIn

© 2026 epocrates, Inc.

download epocrates on app storedownload epocrates on google play

Do not sell or share my personal information

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & Feedback
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information